Literature DB >> 7870974

Altered spontaneous behavior and sensitivity to apomorphine in rats following pretreatment with S(+)-aporphines or fluphenazine.

A Campbell1, R J Baldessarini, J L Neumeyer.   

Abstract

Rats were pretreated for 2 weeks with similarly effective doses of the typical neuroleptic fluphenazine (FPZ) or the experimental weak partial D2 agonists S(+)N-n-propylnorapomorphine (NPA) and S(+)11-hydroxy-N-n-propylnoraporphine (11-OH-NPa). Spontaneous and dopamine (DA) agonist (apomorphine; APO) stimulated stereotyped behaviors or locomotion, and interactions with APO were evaluated over the following 2 weeks. While FPZ induced marked supersensitivity in APO stereotype, (+)NPA showed no significant change, and (+)11-OH-NPa produced only a small, transient increase in response; NPA also lacked a supersensitizing effect on locomotor arousal induced by APO. The time-course of stereotyped responses to APO following pretreatment with FLZ included a marked increase following FPZ that became maximal at day 5 and normalized by day 9; there was a parallel reduction of acute antisteotypy efficacy of FPZ. (+)11-OH-NPa had similar, but much lesser and shorter-lived effects. Spontaneous locomotion was markedly depressed following FPZ, recovered in 1 week, exceeded controls at day 9, and returned to baseline by day 11; (+)11-OH-NPa, again, had similar but smaller effects. Acute effects of FPZ to reduce spontaneous or APO-induced locomotion were greater after FPZ pretreatment and normalized within a week; (+)11-OH-NPa had a similar but smaller effect. Locomotor arousal by APO was altered inconsistently in the week after pretreatment with FPZ or (+)11-OH-NPa. Thus, FPZ appeared to induce tolerance and supersensitivity in central DA systems, most clearly seen following a several-day period to eliminate the drug.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7870974     DOI: 10.1007/bf02244952

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  45 in total

Review 1.  Clozapine. A novel antipsychotic agent.

Authors:  R J Baldessarini; F R Frankenburg
Journal:  N Engl J Med       Date:  1991-03-14       Impact factor: 91.245

Review 2.  Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia.

Authors:  A A Grace
Journal:  Neuroscience       Date:  1991       Impact factor: 3.590

3.  Regional sensitivity of primate brain dopaminergic neurons to haloperidol: alterations following chronic treatment.

Authors:  N G Bacopoulos; G Bustos; D E Redmond; J Baulu; R H Roth
Journal:  Brain Res       Date:  1978-11-24       Impact factor: 3.252

4.  [3H]SCH 23390 binding sites increase after chronic blockade of D-1 dopamine receptors.

Authors:  M L Porceddu; E Ongini; G Biggio
Journal:  Eur J Pharmacol       Date:  1985-12-03       Impact factor: 4.432

Review 5.  Relationship of the actions of neuroleptic drugs to the pathophysiology of tardive dyskinesia.

Authors:  R J Baldessarini; D Tarsy
Journal:  Int Rev Neurobiol       Date:  1979       Impact factor: 3.230

6.  Nigrostriatal lesions enhance striatal 3H-apomorphine and 3H-spiroperidol binding.

Authors:  I Creese; S H Snyder
Journal:  Eur J Pharmacol       Date:  1979-06-15       Impact factor: 4.432

7.  Effects of pindolol and propranolol on beta adrenergic receptors on human lymphocytes.

Authors:  A Hedberg; J G Gerber; A S Nies; B B Wolfe; P B Molinoff
Journal:  J Pharmacol Exp Ther       Date:  1986-10       Impact factor: 4.030

8.  S(+)methylenedioxy-N-n-propylnoraporphine: an orally active inhibitor of dopamine selective for rat limbic system.

Authors:  A Campbell; R J Baldessarini; N S Kula; V J Ram; J L Neumeyer
Journal:  Brain Res       Date:  1987-02-17       Impact factor: 3.252

9.  Prolonged antidopaminergic actions of single doses of butyrophenones in the rat.

Authors:  A Campbell; R J Baldessarini; M H Teicher; N S Kula
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

10.  Neuropharmacology and stereochemistry of dopamine receptor agonist and antagonist enantiomeric pairs.

Authors:  J L Neumeyer; M Froimowitz; R J Baldessarini; A Campbell; Y G Gao
Journal:  J Recept Res       Date:  1988
View more
  2 in total

Review 1.  Interactions between D1 and D2 dopamine receptor family agonists and antagonists: the effects of chronic exposure on behavior and receptor binding in rats and their clinical implications.

Authors:  A R Braun; M Laruelle; M M Mouradian
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

2.  S-(+)-aporphines are not selective for human D3 dopamine receptors.

Authors:  N S Kula; R J Baldessarini; J W Kebabian; J L Neumeyer
Journal:  Cell Mol Neurobiol       Date:  1994-04       Impact factor: 5.046

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.